Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OptionOne Pharmacy is a U.S. specialty pharmacy and home infusion services company focused on providing home and alternate-site infusion therapies for patients with acute and chronic illnesses. The company has offered customized infusion therapy support, including IV antibiotics, total parenteral nutrition, and treatments for chronic diseases such as Crohn's disease, ulcerative colitis, rheumatoid arthritis, and immune deficiencies. OptionOne operated from Oklahoma City and emphasized high-touch clinical monitoring, infusion nursing, and ambulatory infusion center services. The business was acquired by Amerita in December 2020 and appears to continue as an operating business within Amerita's specialty infusion network.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OptionOne Pharmacy.